Compare Godaddy Inc (GDDY) vs Pfizer Inc (PFE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Godaddy Inc vs Pfizer Inc — how do they compare? Godaddy Inc trades at $102.04 (market cap $13.07B), while Pfizer Inc trades at $27.93 (market cap $158.56B). The key difference: Pfizer Inc is far larger — about 12.1× Godaddy Inc's market cap, and Pfizer Inc pays a 6.18% dividend while Godaddy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Godaddy Inc for 65 Days and Pfizer Inc for 158 Days on average.
| GDDY | PFE | |
|---|---|---|
Market Cap | $13.07B | $158.56B |
Volume | 1,831,274 | 44,138,282 |
Sector | Technology | Health |
52-Week High | $135.18 | $29.02 |
52-Week Low | $75.07 | $23.67 |
Typical Hold Time | 65 Days | 158 Days |
Enterprise Value | $15.75B | $210.06B |
Dividend Yield | — | 6.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoDaddy (GDDY) trades at $97.21, down 0.99% on the day, with a bullish technical signal from moving averages and neutral oscillators. The company maintains strong fundamentals with consistent earnings beats, posting $4.95B revenue and $875M net income in 2025. Valuation metrics appear reasonable with P/E of 14.44 and P/S of 2.58. However, the stock faces significant headwinds from multiple securities class action lawsuits alleging misrepresentation of domain contract terms, creating investor uncertainty despite positive financial performance.
The outlook remains mixed with strong operational performance offset by legal risks. Analyst consensus leans bullish with 57.9% buy ratings and $96.20 price target, but the numerous securities lawsuits represent material downside risk. Investors should weigh the company's solid profitability and cash flow generation against potential legal liabilities and reputational damage from the ongoing litigation.
Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.
The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →About Pfizer Inc
Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →
